The Trendlines Group has entered into a definitive collaboration framework agreement with a major multinational medical corporation headquartered in Japan. This research partnership will see the firms mutually identify specific clinical opportunities.
As part of the terms of the agreement, Trendlines Labs will develop innovative medical device products for manufacturing and marketing by the medical corporation.
Trendlines Labs is the in-house innovation center of The Trendlines Group, creating and developing technologies and products to meet critical unmet needs in the medical devices market.
The agreement expands upon a previously established relationship between Trendlines Group and the medical devices firm, under which both the companies explored collaboration efforts. According to a release, both firms have several projects in the development pipeline and are jointly exploring additional fields for product development.